XBIT (STOCKS)
XBiotech Inc
$2.330000
-0.130000 (-5.28%)
Prev close: $2.460000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Sushma Shivaswamy
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $78.01M
- Employees
- 92
- P/E (TTM)
- -1.87
- P/B (TTM)
- 0.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2020 (Q1)
|
$0.00 | $0.06 | -0.0612 | -100.00% |
|
Dec 2019 (Q4)
|
$14.59 | $-0.15 | +14.7430 | +9,635.95% |
|
Sep 2019 (Q3)
|
$-0.15 | $-0.15 | +0.0030 | +1.96% |
|
Jun 2019 (Q2)
|
$-0.16 | $-0.15 | -0.0070 | -4.58% |
Financial Statements
| Nonoperating Income/Loss | $8.50M |
| Research and Development | $40.98M |
| Operating Income/Loss | -$48.41M |
| Income/Loss From Continuing Operations After Tax | -$40.16M |
| Income/Loss From Continuing Operations Before Tax | -$39.91M |
| Income Tax Expense/Benefit | $255.00K |
| Net Income/Loss | -$40.16M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$40.16M |
| Net Income/Loss Available To Common Stockholders, Basic | -$40.16M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.31 |
| Basic Average Shares | 30,487,731 |
| Assets | $139.84M |
| Current Assets | $117.05M |
| Noncurrent Assets | $22.79M |
| Fixed Assets | $22.79M |
| Liabilities | $4.82M |
| Current Liabilities | $3.00M |
| Accounts Payable | $857.00K |
| Other Current Liabilities | $2.14M |
| Noncurrent Liabilities | $1.82M |
| Equity | $135.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $135.02M |
| Liabilities And Equity | $139.84M |
| Net Cash Flow From Operating Activities | -$42.17M |
| Net Cash Flow From Operating Activities, Continuing | -$42.17M |
| Net Cash Flow From Investing Activities | -$186.00K |
| Net Cash Flow From Investing Activities, Continuing | -$186.00K |
| Net Cash Flow From Financing Activities | $10.09M |
| Net Cash Flow From Financing Activities, Continuing | $8.96M |
| Exchange Gains/Losses | $1.92M |
| Net Cash Flow | -$29.21M |
| Net Cash Flow, Continuing | -$31.13M |
| Comprehensive Income/Loss | -$40.16M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.16M |
| Other Comprehensive Income/Loss | $0.00 |